Pharming (PHAR) Work In Process (2020 - 2022)

Pharming (PHAR) has 3 years of Work In Process data on file, last reported at $10.9 million in Q2 2022.

• Quarterly Work In Process rose 75.69% year-over-year to $10.9 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $10.9 million (up 75.69% YoY) and the FY2021 annual result came in at $9.6 million, up 69.48% from the prior year.
• Work In Process climbed to $10.9 million in Q2 2022, from $9.6 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $10.9 million in Q2 2022 to a low of $5.7 million in Q4 2020.
• A 3-year average of $8.1 million and a median of $7.9 million in 2021 frame the typical range for Work In Process.
• Annual changes were most pronounced in 2021 — Work In Process soared 69.48% — and 2022, when it surged 75.69%.
• Tracing PHAR's Work In Process over 3 years: stood at $5.7 million in 2020, then soared by 69.48% to $9.6 million in 2021, then gained by 12.99% to $10.9 million in 2022.
• The last three Work In Process figures came in at $10.9 million (Q2 2022), $9.6 million (Q4 2021), and $6.2 million (Q2 2021), per Business Quant data.